Sugar Editorial Picks
Mar 13, 2009 -
Imagine you know that in a few decades you will be struck with an incurable disease. How much energy would you put into trying to find a cure before it's too late?
Well after learning that he had a genetic mutation that results in a high risk of Parkinson's disease, Google co-founder Sergey Brin has decided to spend millions of dollars on an innovative genetic study, which will attempt to conduct research by, you guessed it, search.
- 4 Comments
Oct 09, 2008 -
One of the ways we motivate ourselves to get involved in races is by adding a bit of philanthropy to it. Apparently, celebrities need the same sort of motivation. Recently, Ryan Reynolds declared that he is going to run the New York City Marathon to raise money for Parkinson's disease (his father has been diagnosed with the disease).
- 3 Comments
May 10, 2007 -
A new drug has been approved by the FDA to treat early Parkinson's disease. I always thought it was a disease that afflicted older folks, but remembered Michael J. Fox was only 30 years old when he announced that he had the disease.
- 3 Comments
Dec 05, 2006 -
Think there's an over the counter drug that could lower your risk of Type 2 diabetes, Parkinson's disease, and colon cancer?
Well, there is, but you won't find it at the pharmacy. Try going to your local coffee shop counter to get a hold of this wonder drug.
- 3 Comments
Other Search Results
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Symptoms
- Risk Factors
- Complications
- Diagnosis
- Treatment
- Levadopa (L-dopa)
- Other Medications
- Surgery
- Lifestyle Changes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approvals
- In 2007, the FDA approved the first skin patch drug for treatment of Parkinson’s disease. Transdermal rotigotine (Neupro) is a dopamine agonist drug that may help improve symptoms of early-stage Parkinson’s disease. The patch is applied daily.
- Rivastigimine (Exelon), an Alzheimer’s disease drug, was approved in 2006 for treatment of mild-to-moderate dementia associated with Parkinson’s disease.
Drug Withdrawal
In 2007, the FDA withdrew the dopamine agonist pergolide (Permax) from the market due to safety concerns.
- 2 Comments
Sep 03, 2008 -
Overview
- Definition
- Alternative Names
- Causes, incidence, and risk factors
- Symptoms
- Signs and tests
- Treatment
- Support Groups
- Expectations (prognosis)
- Complications
- Calling your health care provider
- References
Illustrations
Substantia nigra and Parkinson's disease
Central nervous system
HEALTH GUIDE REFERENCE FROM A.D.A.M
Definition
Parkinson's disease is a disorder of the brain that leads to shaking (tremors) and difficulty with walking, movement, and coordination.
Alternative Names
Paralysis agitans; Shaking palsy
Causes, incidence, and risk factors
Parkinson's disease was first described in England in 1817 by Dr. James Parkinson.
- 0 Comments
Oct 08, 2008 -
Overview
- Signs and Symptoms
- What Causes It?
- What to Expect at Your Provider's Office
- Treatment Options
- Following Up
- Special Considerations
- Supporting Research
HEALTH GUIDE REFERENCE FROM A.D.A.M
Parkinson's disease is a progressive disorder of the central nervous system. Nerve cells in the brain that control movement deteriorate and die, causing problems with movement, especially tremors in the hands and rigidity in the face. The disease affects men and women equally, primarily after age 60.
- 0 Comments
Sep 04, 2008 -
Overview
- Alternative Names
- Information
Illustrations
Support group counselors
HEALTH GUIDE REFERENCE FROM A.D.A.M
Alternative Names
Resources - Parkinson's disease
Information
The following organizations are good resources for information on Parkinson's disease:
- American Parkinson Disease Association - www.apdaparkinson.org
- National Parkinson Foundation - www.parkinson.org
- Michael J. Fox Foundation for Parkinson's Research - www.michaeljfox.com
- Parkinson's Disease Foundation, Inc. - www.pdf.org
Review Date: 10/13/2006
Reviewed By: A.D.A.M.
- 0 Comments
Sep 04, 2008 -
Back
HEALTH GUIDE REFERENCE FROM A.D.A.M
Parkinson’s disease is a slowly progressive disorder that affects movement, muscle control, and balance. Part of the disease process develops as cells are destroyed in certain parts of the brain stem, particularly the crescent-shaped cell mass known as the substantia nigra. Nerve cells in the substantia nigra send out fibers to tissue located in both sides of the brain. There the cells release essential neurotransmitters that help control movement and coordination.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Prevention
- Symptoms
- Diagnosis
- Medications
- Stages
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Alzheimer’s Disease Toll Increasing
More than 5 million Americans now have Alzheimer’s disease, and the number could increase to 16 million by mid-century, according to a 2007 report from the Alzheimer’s Association.
New Drug Indication
In 2006, the FDA expanded the use of donepezil (Aricept) to include treatment of people with severe dementia associated with Alzheimer’s disease. Donepezil was previously approved only for people with mild-to-moderate dementia.
- 1 Comment